Related Experiment Video
Updated: Jul 16, 2026

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
Nitric Oxide in Cardiac Surgery: A Review Article
Nikolay O Kamenshchikov1, Nicolette Duong2,3,4, Lorenzo Berra2,3,4
1Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634012 Tomsk, Russia.
Nitric oxide (NO) shows promise for protecting organs during cardiac surgery. Further research is needed to establish NO therapy for improved patient outcomes and identify optimal patient groups.
Area of Science:
- Cardiology
- Physiology
- Pharmacology
Background:
- Perioperative organ injury is a significant challenge in cardiac surgery, leading to increased morbidity, mortality, and healthcare costs.
- Current interventions are insufficient to mitigate multiple organ dysfunction following cardiac surgery.
- Identifying agents that promote organ protection during this critical period is essential.
Purpose of the Study:
- To review the potential of nitric oxide (NO) as an agent for perioperative organ and tissue protection, particularly in the heart-kidney axis.
- To evaluate the existing clinical data and physiological research supporting NO's application in cardiac surgery.
- To highlight NO's role in potentially improving patient outcomes.
Main Methods:
- Literature review of basic science, physiological research, and clinical studies on nitric oxide in cardiac surgery.
- Analysis of NO's properties, delivery methods, cost-effectiveness, and safety profile.
- Examination of NO's impact on perioperative organ protection, focusing on the heart-kidney axis.
Main Results:
- Nitric oxide (NO) demonstrates significant potential for perioperative organ protection, especially concerning the heart-kidney axis.
- NO administration is clinically feasible, cost-effective, and associated with known, manageable side effects.
- Existing data supports NO as a safe and promising approach for perioperative management in cardiac surgery.
Conclusions:
- Nitric oxide (NO) is a safe and promising agent for perioperative organ protection in cardiac surgery.
- Further clinical research is necessary to define NO's role as an adjunct therapy and optimize its application.
- Identifying patient responders and optimal delivery modes for perioperative NO therapy is crucial for clinical implementation.
More Related Videos
Related Concept Videos
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Vasodilators
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Angina V: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Aneurysm IV: Nursing Management

